Showing results (11-20 of 1,538) with videos related to
Sort By:
Pageof 154
Cancer Reports (Hoboken, N.J.)|July 10, 2021
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institutionSiddharth Menon, Amy Davies, Sophia Frentzas, et al.Cancer Reports (Hoboken, N.J.)|May 27, 2021
The effects of ARID1A mutations on colorectal cancer and associations with PD-L1 expression by stromal cellsTomohiro Kamori, Eiji Oki, Yoshifumi Shimada, et al.Cancer Reports (Hoboken, N.J.)|June 11, 2021
Bladder and upper urinary tract cancers as first and second primary cancersGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.Cancer Reports (Hoboken, N.J.)|June 15, 2022
Disabled, invisible and dismissed-The lived experience of fatigue in people with myeloproliferative neoplasmsAshleigh Bradford, Ken Young, Ashley Whitechurch, et al.Cancer Reports (Hoboken, N.J.)|November 22, 2022
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosisFabia de Oliveira Andrade, Vivek Verma, Leena Hilakivi-ClarkeCancer Reports (Hoboken, N.J.)|December 23, 2022
MAP3K1 rs889312 polymorphism and cancer prognosis: A systematic review and meta-analysisMd Abdul Aziz, Mohammad Safiqul IslamCancer Reports (Hoboken, N.J.)|June 22, 2021
Langerhans cell histiocytosis: Presentation in a preterm neonateAna Fadhel Alvarez, Shaily P Patel, Maya I Brasher, et al.Cancer Reports (Hoboken, N.J.)|June 24, 2021
High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcomeIosif Strouthos, Efstratios Karagiannis, Nikolaos Zamboglou, et al.Cancer Reports (Hoboken, N.J.)|December 14, 2022
FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case reportSalhah Ali, Yasmine Al-Qattan, Walaa Awny, et al.Cancer Reports (Hoboken, N.J.)|December 19, 2022
Anti-cancer effect of entacaponeon esophageal cancer cells via apoptosis induction and cell cycle modulationFahimeh Ramedani, Seyyed Mehdi Jafari, Marie Saghaeian Jazi, et al.Pageof 154